Catheter Precision, Inc. announced on June 12, 2025, that LockeT sales for the second quarter of 2025 are on track to be the highest to date. This indicates significant commercial momentum for the suture retention device.
Second quarter 2025 LockeT sales are already outpacing Q2 2024 sales with a 200% increase. This substantial growth highlights increasing market acceptance and demand for the product.
The company also reported that several US hospitals are on track to issue more than $100,000 in purchase orders for LockeT. This demonstrates growing adoption among key healthcare institutions and contributes to the product's expanding commercial footprint.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.